Adeno-associated vector (Type 8)-mediated expression of soluble flt-1 efficiently inhibits neovascularization in a murine choroidal neovascularization model

Human Gene Therapy

Volumn 21, Issue 5, 2010, Pages 631-637

  Igarashi, Tsutomu ^a   Miyake, Koichi ^a   Masuda, Ikuya ^b   Takahashi, Hiroshi ^a   Shimada, Takashi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; PARVOVIRUS VECTOR; VASCULOTROPIN RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENDOTHELIUM CELL; FEASIBILITY STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO GENE TRANSFER; MALE; MOUSE; NONHUMAN; SUBRETINAL NEOVASCULARIZATION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT;

ANIMALS; CHOROID; CHOROIDAL NEOVASCULARIZATION; GENE THERAPY; GENETIC VECTORS; HUMANS; INJECTIONS; LAC OPERON; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; RETINA; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

MURINAE; MUS;

EID: 77950928559     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.153     Document Type: Article

References (39)

1. Alon, T., Hemo, I., Itin, A., Pe'er, J., Stone, J., and Keshet, E. (1995). Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med. 1, 1024-1028.
2. Bainbridge, J.W., and Ali, R.R. (2008). Keeping an eye on clinical trials in 2008. Gene Ther. 15, 633-634.
3. Bennett, J., and Maguire, A.M. (2000). Gene therapy for ocular disease. Mol. Ther. 1, 501-505.
4. 2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Muller cells. Invest. Ophthalmol. Vis. Sci. 39, 581-591.
5. Coleman, H.R., Chan, C.C., Ferris, F.L., III, and Chew, E.Y. (2008). Age-related macular degeneration. Lancet 372, 1835-1845.
6. Congdon, N., O'Colmain, B., Klaver, C.C., Klein, R., Munoz, B., Friedman, D.S., Kempen, J., Taylor, H.R., and Mitchell, P. (2004). Causes and prevalence of visual impairment among adults in the United States. Arch. Ophthalmol. 122, 477-485. (Pubitemid 38456282)
7. de Vries, C., Escobedo, J.A., Ueno, H., Houck, K., Ferrara, N., and Williams, L.T. (1992). The Fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255, 989-991.
8. Ferrara, N., Houck, K.A., Jakeman, L.B., Winer, J., and Leung, D.W. (1991). The vascular endothelial growth factor family of polypeptides. J. Cell Biochem. 47, 211-218.
9. Gehlbach, P., Demetriades, A.M., Yamamoto, S., Deering, T., Xiao, W.H., Duh, E.J., Yang, H.S., Lai, H., Kovesdi, I., Carrion, M., Wei, L., and Campochiaro, P.A. (2003). Periocular gene transfer of sFlt-1 suppresses ocular neovascularization and vascular endothelial growth factor-induced breakdown of the blood-retinal barrier. Hum. Gene Ther. 14, 129-141.
10. Gragoudas, E.S., Adamis, A.P., Cunningham, E.T., Jr., Feinsod, M., and Guyer, D.R. (2004). Pegaptanib for neovascular age-related macular degeneration. N. Engl. J. Med. 351, 2805-2816.
11. Hera, R., Keramidas, M., Peoc'h, M., Mouillon, M., Romanet, J.P., and Feige, J.J. (2005). Expression of VEGF and angio-poietins in subfoveal membranes from patients with age-related macular degeneration. Am. J. Ophthalmol. 139, 589-596.
12. Honda, M., Sakamoto, T., Ishibashi, T., Inomata, H., and Ueno, H. (2000). Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF=flt-1 receptor gene transfection: A role of VEGF and possible treatment for SRN in age-related macular degeneration. Gene Ther. 7, 978-985.
13. Hotchkiss, M.L., and Fine, S.L. (1981). Pathologic myopia and choroidal neovascularization. Am. J. Ophthalmol. 91, 177-183.
14. Igarashi, T., Miyake, K., Kato, K., Watanabe, A., Ishizaki, M., Ohara, K., and Shimada, T. (2003). Lentivirus-mediated expression of angiostatin efficiently inhibits neovascularization in a murine proliferative retinopathy model. Gene Ther. 10, 219-226.
15. Ip, M.S., Scott, I.U., Brown, G.C., Brown, M.M., Ho, A.C., Huang, S.S., and Recchia, F.M. (2008). Anti-vascular endo-thelial growth factor pharmacotherapy for age-related macu-lar degeneration: A report by the American Academy of Ophthalmology. Ophthalmology 115, 1837-1846.
16. Kaiser, P.K. (2006). Antivascular endothelial growth factor agents and their development: Therapeutic implications in ocular diseases. Am. J. Ophthalmol. 142, 660-668.
17. Keck, P.J., Hauser, S.D., Krivi, G., Sanzo, K., Warren, T., Feder, J., and Connolly, D.T. (1989). Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246, 1309-1312. (Pubitemid 20066717)
18. Kurai, T., Hisayasu, S., Kitagawa, R., Migita, M., Suzuki, H., Hirai, Y., and Shimada, T. (2007). AAV1 mediated co-expression of formylglycine-generating enzyme and aryl-sulfatase A efficiently corrects sulfatide storage in a mouse model of metachromatic leukodystrophy. Mol. Ther. 15, 38-43.
19. Kvanta, A., Algvere, P.V., Berglin, L., and Seregard, S. (1996). Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest. Ophthalmol. Vis. Sci. 37, 1929-1934.
20. Lai, C.M., Shen, W.Y., Brankov, M., Lai, Y.K., Barnett, N.L., Lee, S.Y., Yeo, I.Y., Mathur, R., Ho, J.E., Pineda, P., Barathi, A., Ang, C.L., Constable, I.J., and Rakoczy, E.P. (2005). Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys. Mol. Ther. 12, 659-668.
21. Lai, Y.K., Shen, W.Y., Brankov, M., Lai, C.M., Constable, I.J., and Rakoczy, P.E. (2002). Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy. Gene Ther. 9, 804-813.
22. Lebherz, C., Maguire, A., Tang, W., Bennett, J., and Wilson, J.M. (2008). Novel AAV serotypes for improved ocular gene transfer. J. Gene Med. 10, 375-382.
23. Maguire, A.M., Simonelli, F., Pierce, E.A., Pugh, E.N., Jr., Min-gozzi, F., Bennicelli, J., Banfi, S., Marshall, K.A., Testa, F., Surace, E.M., Rossi, S., Lyubarsky, A., Arruda, V.R., Konkle, B., Stone, E., Sun, J., Jacobs, J., Dell'osso, L., Hertle, R., Ma, J.X., Redmond, T.M., Zhu, X., Hauck, B., Zelenaia, O., Shindler, K.S., Maguire, M.G., Wright, J.F., Volpe, N.J., McDonnell, J.W., Auricchio, A., High, K.A., and Bennett, J. (2008). Safety and efficacy of gene transfer for Leber's congenital amaurosis. N. Engl. J. Med. 358, 2240-2248.
24. Miyake, K., Inokuchi, K., Dan, K., and Nomura, T. (1993). Alterations in the deleted in colorectal carcinoma gene in human primary leukemia. Blood 82, 927-930.
25. Mori, K., Ando, A., Gehlbach, P., Nesbitt, D., Takahashi, K., Goldsteen, D., Penn, M., Chen, C.T., Melia, M., Phipps, S., Moffat, D., Brazzell, K., Liau, G., Dixon, K.H., and Campo-chiaro, P.A. (2001). Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing se-cretable endostatin. Am. J. Pathol. 159, 313-320.
26. Mori, K., Gehlbach, P., Yamamoto, S., Duh, E., Zack, D.J., Li, Q., Berns, K.I., Raisler, B.J., Hauswirth, W.W., and Campochiaro, P.A. (2002). AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovasculariza-tion. Invest. Ophthalmol. Vis. Sci. 43, 1994-2000.
27. Mustonen, T., and Alitalo, K. (1995). Endothelial receptor tyro-sine kinases involved in angiogenesis. J. Cell Biol. 129, 895-898.
28. Ng, E.W., Shima, D.T., Calias, P., Cunningham, E.T., Jr., Guyer, D.R., and Adamis, A.P. (2006). Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat. Rev. Drug Discov. 5, 123-132.
29. Noro, T., Miyake, K., Suzuki-Miyake, N., Igarashi, T., Uchida, E., Misawa, T., Yamazaki, Y., and Shimada, T. (2004). Adeno-associated viral vector-mediated expression of en-dostatin inhibits tumor growth and metastasis in an ortho-tropic pancreatic cancer model in hamsters. Cancer Res. 64, 7486-7490.
30. Rosenfeld, P.J., Brown, D.M., Heier, J.S., Boyer, D.S., Kaiser, P.K., Chung, C.Y., and Kim, R.Y. (2006). Ranibizumab for neovas-cular age-related macular degeneration. N. Engl. J. Med. 355, 1419-1431.
31. Rota, R., Riccioni, T., Zaccarini, M., Lamartina, S., Gallo, A.D., Fusco, A., Kovesdi, I., Balestrazzi, E., Abeni, D.C., Ali, R.R., and Capogrossi, M.C. (2004). Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer. J. Gene Med. 6, 992-1002.
32. Senger, D.R., Galli, S.J., Dvorak, A.M., Perruzzi, C.A., Harvey, V.S., and Dvorak, H.F. (1983). Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983-985.
33. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843-845.
34. Sickenberg, M., Schmidt-Erfurth, U., Miller, J.W., Pournaras, C.J., Zografos, L., Piguet, B., Donati, G., Laqua, H., Barbazetto, I., Gragoudas, E.S., Lane, A.M., Birngruber, R., Van Den Bergh, H., Strong, H.A., Manjuris, U., Gray, T., Fsadni, M., and Bressler, N.M. (2000). A preliminary study of photody-namic therapy using verteporfin for choroidal neovascular-ization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch. Ophthalmol. 118, 327-336.
35. Starr, C.E., Guyer, D.R., and Yannuzzi, L.A. (1998). Age-related macular degeneration: Can we stem this worldwide public health crisis? Postgrad. Med. 103, 153-156, 161-1154
36. Takahashi, H., Hirai, Y., Migita, M., Seino, Y., Fukuda, Y., Sakuraba, H., Kase, R., Kobayashi, T., Hashimoto, Y., and Shimada, T. (2002). Long-term systemic therapy of Fabry disease in a knockout mouse by adeno-associated virus-mediated muscle-directed gene transfer. Proc. Natl. Acad. Sci. U.S.A. 99, 13777-13782.
37. Yang, G.S., Schmidt, M., Yan, Z., Lindbloom, J.D., Harding, T.C., Donahue, B.A., Engelhardt, J.F., Kotin, R., and Davidson, B.L. (2002). Virus-mediated transduction of murine retina with adeno-associated virus: Effects of viral capsid and genome size. J. Virol. 76, 7651-7660.
38. Yi, X., Ogata, N., Komada, M., Yamamoto, C., Takahashi, K., Omori, K., and Uyama, M. (1997). Vascular endothelial growth factor expression in choroidal neovascularization in rats. Graefes Arch. Clin. Exp. Ophthalmol. 235, 313-319.
39. Young, R.W. (1987). Pathophysiology of age-related macular degeneration. Surv. Ophthalmol. 31, 291-306.